Patent 7342093 was granted and assigned to University of Massachusetts on March, 2008 by the United States Patent and Trademark Office.
Disclosed herein are compounds that inhibit Hsp90 interactions with IAP proteins, such as Survivin, XIAP, cIAP1, or cIAP2, and methods for identifying and using such compounds.